Paraoxonase and arylesterase activities of serum PON1 in young heal thy Bulgarian subjects

被引：0
|
作者：
Doneva-Basheva, Krastinka [1 ]
Vlaykova, T. [1 ]
机构：
[1] Trakia Univ Stara Zagora, Stara Zagora, Bulgaria
来源：
EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
714
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [21] Paraoxonase (PON1) and organophosphate toxicity
    Costa, L. G.
    Cole, T. B.
    Jansen, K. L.
    Furlong, C. E.
    PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM, 2008, 6 : 209 - +
  • [22] GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
    Ginsberg, Gary
    Neafsey, Patricia
    Hattis, Dale
    Guyton, Kathryn Z.
    Johns, Douglas O.
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 473 - 507
  • [23] Further characterization of human serum paraoxonase (PON1) lactonase activity
    Billecke, S
    Draganov, D
    Counsell, R
    Stetson, P
    Watson, C
    Hsu, C
    La Du, BN
    FASEB JOURNAL, 2000, 14 (08): : A1323 - A1323
  • [24] PARAOXONASE 1 (PON1) GENE POLYMORPHISMS, PON1 EXPRESSION IN PBMCS, AND SERUM PON1 ACTIVITY CONCERNING DYSLIPIDEMIA AND RELATED COMORBIDITIES IN HEMODIALYSIS (HD) PATIENTS
    Grzegorzewska, Alicja Ewa
    Lwanczyk-Skalska, Ewa
    Adamska, Paulina
    Niepolski, Leszek
    Mostowska, Adrianna
    Warchol, Wojciech
    Jagodzinski, Pawel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1598 - 1598
  • [25] Naringenin is an inhibitor of human serum paraoxonase (PON1): An in vitro study
    Mahrooz, Abdolkarim
    Rashidi, Mohammad-Reza
    Nouri, Mohammad
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S249 - S249
  • [26] Naringenin is An Inhibitor of Human Serum Paraoxonase (PON1): An In Vitro Study
    Mahrooz, Abdolkarim
    Rashidi, Mohammad-Reza
    Nouri, Mohammad
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2011, 25 (06) : 395 - 401
  • [27] Human Plasma Paraoxonase 1 (PON1) Arylesterase Activity During Aging: Correlation with Susceptibility of LDL Oxidation
    Mehdi, Mohammad Murtaza
    Rizvi, Syed Ibrahim
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (06) : 438 - 443
  • [28] Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
    Ronsein, Graziella E.
    Reyes-Soffer, Gissette
    He, Yi
    Oda, Michael
    Ginsberg, Henry
    Heinecke, Jay W.
    MOLECULAR & CELLULAR PROTEOMICS, 2016, 15 (03) : 1083 - 1093
  • [29] Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects
    Sirivarasai, Jintana
    Kaojarern, Sming
    Yoovathaworn, Krongtong
    Sura, Thanyachai
    CHEMICO-BIOLOGICAL INTERACTIONS, 2007, 168 (03) : 184 - 192
  • [30] Evaluation of Serum Paraoxonase and Arylesterase Activities in Subjects with Asthma and Chronic Obstructive Lung Disease
    Acay, A.
    Erdenen, F.
    Altunoglu, E.
    Erman, H.
    Muderrisoglu, C.
    Korkmaz, G. G.
    Gelisgen, R.
    Tabak, O.
    Uzun, H.
    CLINICAL LABORATORY, 2013, 59 (11-12) : 1331 - 1337
12345